Preliminary Validation Study of the French-Quebec Version of the Mild Behavioral Impairment Checklist.

IF 1.3 4区医学 Q4 BEHAVIORAL SCIENCES

Cognitive and Behavioral Neurology Pub Date : 2023-03-01 DOI:10.1097/WNN.0000000000000321

Émilie Pépin, Noémie Tanguay, Marie-Pier Roy, Joël Macoir, Marie-Andrée Bruneau, Zahinoor Ismail, Carol Hudon

{"title":"Preliminary Validation Study of the French-Quebec Version of the Mild Behavioral Impairment Checklist.","authors":"Émilie Pépin, Noémie Tanguay, Marie-Pier Roy, Joël Macoir, Marie-Andrée Bruneau, Zahinoor Ismail, Carol Hudon","doi":"10.1097/WNN.0000000000000321","DOIUrl":null,"url":null,"abstract":"Background: Alzheimer disease dementia may be preceded by cognitive stages during which behavioral and psychological changes can occur. More precisely, behavioral symptoms may be observed during the subjective cognitive decline (SCD) or the mild cognitive impairment (MCI) stages; these symptoms can be measured using the Mild Behavioral Impairment Checklist (MBI-C).Objective: To validate the French-Quebec version of the MBI-C in individuals ages 60-85 years.Method: The sample included 60 participants (20 MCI, 20 SCD, 20 cognitively healthy) and their informants. To assess the discriminant validity of the MBI-C, a Kruskal-Wallis analysis with a multiple comparisons test was performed on the MBI-C Total score. To determine convergent validity, Spearman correlations were calculated between the MBI-C subscales and a set of validation tools. Finally, test-retest reliability was assessed with Spearman correlations of MBI-C scores between two test sessions.Results: All of the analyses indicated satisfactory psychometric properties for the French-Quebec version of the MBI-C.Conclusion: This validation study reveals that the MBI-C can be used successfully in dementia risk assessments. From now on, the use of a validated MBI-C will be possible in the French-Quebec population.","PeriodicalId":50671,"journal":{"name":"Cognitive and Behavioral Neurology","volume":"36 1","pages":"9-18"},"PeriodicalIF":1.3000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cognitive and Behavioral Neurology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/WNN.0000000000000321","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BEHAVIORAL SCIENCES","Score":null,"Total":0}

引用次数: 1

Abstract

Background: Alzheimer disease dementia may be preceded by cognitive stages during which behavioral and psychological changes can occur. More precisely, behavioral symptoms may be observed during the subjective cognitive decline (SCD) or the mild cognitive impairment (MCI) stages; these symptoms can be measured using the Mild Behavioral Impairment Checklist (MBI-C).

Objective: To validate the French-Quebec version of the MBI-C in individuals ages 60-85 years.

Method: The sample included 60 participants (20 MCI, 20 SCD, 20 cognitively healthy) and their informants. To assess the discriminant validity of the MBI-C, a Kruskal-Wallis analysis with a multiple comparisons test was performed on the MBI-C Total score. To determine convergent validity, Spearman correlations were calculated between the MBI-C subscales and a set of validation tools. Finally, test-retest reliability was assessed with Spearman correlations of MBI-C scores between two test sessions.

Results: All of the analyses indicated satisfactory psychometric properties for the French-Quebec version of the MBI-C.

Conclusion: This validation study reveals that the MBI-C can be used successfully in dementia risk assessments. From now on, the use of a validated MBI-C will be possible in the French-Quebec population.

查看原文本刊更多论文

法国魁北克版轻度行为障碍检查表的初步验证研究。

背景：阿尔茨海默病痴呆之前可能有认知阶段，在此期间可能会发生行为和心理变化。更确切地说，行为症状可以在主观认知能力下降（SCD）或轻度认知障碍（MCI）阶段观察到；这些症状可以使用轻度行为障碍检查表（MBI-C）进行测量。目的：在60-85岁的人群中验证法国魁北克版的MBI-C。方法：样本包括60名参与者（20名MCI，20名SCD，20名认知健康）及其信息提供者。为了评估MBI-C的判别有效性，对MBI-C总分进行了Kruskal-Wallis分析和多重比较测试。为了确定收敛有效性，计算了MBI-C分量表和一组验证工具之间的Spearman相关性。最后，通过两次测试之间MBI-C分数的Spearman相关性来评估重测的可靠性。结果：所有分析均表明法国魁北克版MBI-C具有令人满意的心理测量特性。结论：本验证研究表明，MBI-C可成功用于痴呆风险评估。从现在起，经过验证的MBI-C将有可能在法国魁北克省人群中使用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cognitive and Behavioral Neurology 医学-行为科学

CiteScore

2.40

自引率

7.10%

发文量

审稿时长

>12 weeks

期刊介绍： Cognitive and Behavioral Neurology (CBN) is a forum for advances in the neurologic understanding and possible treatment of human disorders that affect thinking, learning, memory, communication, and behavior. As an incubator for innovations in these fields, CBN helps transform theory into practice. The journal serves clinical research, patient care, education, and professional advancement. The journal welcomes contributions from neurology, cognitive neuroscience, neuropsychology, neuropsychiatry, and other relevant fields. The editors particularly encourage review articles (including reviews of clinical practice), experimental and observational case reports, instructional articles for interested students and professionals in other fields, and innovative articles that do not fit neatly into any category. Also welcome are therapeutic trials and other experimental and observational studies, brief reports, first-person accounts of neurologic experiences, position papers, hypotheses, opinion papers, commentaries, historical perspectives, and book reviews.